Oral Dehydroepiandrosterone for Adrenal Androgen Replacement: Pharmacokinetics and Peripheral Conversion to Androgens and Estrogens in Young Healthy Females after Dexamethasone Suppression
The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Abstract
Women with adrenal insufficiency suffer from chronic dehydroepiandrosterone (sulfate) [DHEA(S)] deficiency. To define a suitable dose for DHEA replacement, we studied the pharmacokinetics and biotransformation of orally administered DHEA in nine healthy female volunteers (mean age 23.3 +/- 4.1 yr, mean body mass index 22.5 +/- 1.8 kg/m2) with transient suppression of adrenal androgen secretion because of dexamethasone (dex) administration (4 x 0.5 mg/day for 4 days). Diurnal blood sampling was performed during the early follicular phase of four subsequent menstrual cycles (study period 1: baseline; study periods 2-4: dex + placebo, dex + 50 mg DHEA or dex + 100 mg DHEA in a randomized cross-over design). Dex induced not only a significant suppression of serum cortisol (to 8% of baseline) but also of DHEA (18%), DHEA(S) (16%), and androstenedione (26%), as well as of testosterone (28%), dihydrotestosterone (43%), and estrone (54%). Oral administration of 50 mg DHEA led to restoration of DHEA(S) baseline levels, whereas 100 mg induced supraphysiological concentrations [baseline vs. 50 mg DHEA vs. 100 mg DHEA: area under the concentration-time curve (AUC) 0-12 h DHEA: 280 +/- 85 vs. 241 +/- 73 vs. 383 +/- 106 nmol/L x h; AUC 0-12 h DHEA(S): 89.1 +/- 48.4 vs. 139.6 +/- 43.5 vs. 213.3 +/- 21.6 mumol/L x h). Serum concentrations of dihydrotestosterone and estrone were restored to baseline after 50 mg DHEA, whereas baseline testosterone and androstenedione levels were only achieved by administration of 100 mg DHEA. In conclusion, 50 mg DHEA seems to be a suitable replacement dose in females with adrenal insufficiency. Furthermore, the rapid and lasting conversion to potent androgens demonstrates a potential role of DHEA for androgen replacement in females in general.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Suppression of adrenal androgen output by dexamethasone in healthy, young women with a regular menstrual cycle leads to a 90% decrease in DHEA(S) output, but also reduces circulating testosterone and DHT concentrations to one third of their respective baseline concentrations [81].”
From Human steroid biosynthesis, metabolism and excretion are differentially reflected by serum and urine steroid metabolomes: a comprehensive review (2019) · cites this paper as [81]
In the citing paper
“However, while administration of DHEA yields significant increases in both DHEAS and active androgens (Arlt et al., 1998, Arlt et al., 1999b), the administration of DHEAS does not result in any increase of DHEA and downstream androgens in healthy adults (Hammer et al., 2005).”
From Intracrine androgen biosynthesis, metabolism and action revisited (2018) · cites this paper as Arlt et al., 1998
In the citing paper
“The oral daily dose of 50 mg, however, has been found as the one providing physiological concentrations of androgens and estrogens (73,74,300,335).”
From Endocrine and intracrine sources of androgens in women: inhibition of breast cancer and other roles of androgens and their precursor dehydroepiandrosterone (2003) · cites this paper as [300]
Citations
Cites
ORENTREICH, N., BRIND, J. L., RIZER, R. L., & VOGELMAN, J. H. (1984) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-59-3-551 · Cited by 1,349
GRAY, A., FELDMAN, H. A., MCKINLAY, J. B., & LONGCOPE, C. (1991) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-73-5-1016 · Cited by 1,118
Effects of replacement dose of dehydroepiandrosterone in men and women of advancing age.
Morales, A. J., Nolan, J. J., Nelson, J. C., & Yen, S. S. (1994) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.78.6.7515387 · Cited by 841
Ovarian and adrenal contribution to peripheral androgens during the menstrual cycle
ABRAHAM, G. E. (1974) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-39-2-340 · Cited by 436
Long-term longitudinal measurements of plasma dehydroepiandrosterone sulfate in normal men
Orentreich, N., Brind, J. L., Vogelman, J. H., Andres, R., & Baldwin, H. (1992) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.75.4.1400863 · Cited by 417
NESTLER, J. E., BARLASCINI, C. O., CLORE, J. N., & BLACKARD, W. G. (1988) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-66-1-57 · Cited by 414
Dehydroepiandrosterone (DHEA): a fountain of youth?
Baulieu, E. E. (1996) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.81.9.3147 · Cited by 381
Labrie, F., Bélanger, A., Cusan, L., & Candas, B. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.8.4161 · Cited by 350
The effects of oral dehydroepiandrosterone on endocrine-metabolic parameters in postmenopausal women
MORTOLA, J. F., & YEN, S. S. C. (1990) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-71-3-696 · Cited by 311
Berr, C., Lafont, S., Debuire, B., Dartigues, J.-F., & Baulieu, E.-E. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.23.13410 · Cited by 292
Cited by
Items 101–197 of 197
Marder, W., Somers, E. C., Kaplan, M. J., Anderson, M. D., Lewis, E., & McCune, W. J. (2010) · Lupus · doi:10.1177/0961203310371156 · Cited by 24
Ceresini, G., Morganti, S., Rebecchi, I., Freddi, M., Ceda, G. P., Banchini, A., Solerte, S. B., Ferrari, E., Ablondi, F., & Valenti, G. (2000) · Metabolism · doi:10.1016/s0026-0495(00)80024-4 · Cited by 24
Dehydroepiandrosterone (DHEA) supplementation and IVF outcome in poor responders
Triantafyllidou, O., Sigalos, G. Α., & Vlahos, N. (2016) · Human Fertility · doi:10.1080/14647273.2016.1262065 · Cited by 22
do Nascimento, G. R. A., Barros, Y., Wells, A. K., & Khalil, R. A. (2009) · Current Hypertension Reviews · doi:10.2174/157340209789587717 · Cited by 23
Clinical Implications of Androgen Synthesis via 5&agr;-Reduced Precursors
Ghayee, H. K., & Auchus, R. J. (2008) · KARGER eBooks · doi:10.1159/000134780 · Cited by 23
Bioavailability and Pharmacokinetics of Dehydroepiandrosterone in the Cynomolgus Monkey
Leblanc, M., Labrie, C., Bélanger, A., Candas, B., & Labrie, F. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-022012 · Cited by 21
Genetic influence of an ACTH receptor promoter polymorphism on adrenal androgen secretion
Reisch, N., Slawik, M., Zwermann, O., Beuschlein, F., & Reincke, M. (2005) · European Journal of Endocrinology · doi:10.1530/eje.1.02015 · Cited by 20
Self-citationCardiovascular Physiology of Androgens and Androgen Testosterone Therapy in Postmenopausal Women
Ling, S., Komesaroff, P. A., & Sudhir, K. (2009) · Endocrine Metabolic & Immune Disorders - Drug Targets · doi:10.2174/187153009787582414 · Cited by 19
Hormonal status of cortisol and dehydroepiandrosterone sulfate in an elderly Tunisian population
Chehab, O., Ouertani, M., Chaieb, K., Haouala, F., & Mahdouani, K. (2007) · Comptes Rendus Biologies · doi:10.1016/j.crvi.2007.08.004 · Cited by 23
Song, L., Xue Ming, T. A. N. G., Kong, Y., Ma, H., & Zou, S. (2009) · Steroids · doi:10.1016/j.steroids.2009.11.007 · Cited by 17
Functions of dehydroepiandrosterone in relation to breast cancer
Chatterton, R. T. (2022) · Steroids · doi:10.1016/j.steroids.2022.108970 · Cited by 20
Corrigan, B. (2002) · Clinical Journal of Sport Medicine · doi:10.1097/00042752-200207000-00006 · Cited by 21
Dehydroepiandrosterone to Enhance Physical Performance: Myth and Reality
Hahner, S., & Allolio, B. (2010) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2009.10.008 · Cited by 17
Self-citationLi, L., Ge, C., Wang, D., Yu, L., Zhao, J., & Ma, H. (2018) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2018.03.007 · Cited by 16
Liu, L., Kang, J., Ding, X. L., Chen, D., Zhou, Y., & Ma, H. (2015) · Cellular Physiology and Biochemistry · doi:10.1159/000430150 · Cited by 17
Pharmacokinetics of oral dehydroepiandrosterone (DHEA) in the ovariectomised cynomolgus monkey
Leblanc, M., Labrie, C., Bélanger, A., Candas, B., & Labrie, F. (2002) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(02)00059-6 · Cited by 16
Therapies for adrenal insufficiency
Oki, K., & Yamane, K. (2007) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.8.9.1283 · Cited by 18
Hunt, P. J., Gurnell, E. M., Huppert, F. A., Richards, C., Prevost, A. T., Wass, J. A. H., Herbert, J., & Chatterjee, V. K. K. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.12.7022 · Cited by 386
Zimmerman, Y., Foidart, J. M., Pintiaux, A., Minon, J., Fauser, B. C. J. M., Cobey, K. D., & Bennink, H. J. T. C. (2014) · Contraception · doi:10.1016/j.contraception.2014.11.008 · Cited by 16
Consensus Document on substitution therapy with DHEA in the elderly
Valenti, G., Denti, L., Saccò, M., Ceresini, G., Bossoni, S., Giustina, A., Maugeri, D., Vigna, G. B., Fellin, R., Paolisso, G., et al. (2006) · Aging Clinical and Experimental Research · doi:10.1007/bf03324662 · Cited by 15
Is DHEA replacement beneficial in chronic adrenal failure?
Lang, K., Burger‐Stritt, S., & Hahner, S. (2014) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2014.09.007 · Cited by 17
Zimmerman, Y., Foidart, J. M., Pintiaux, A., Minon, J., Fauser, B. C. J. M., Cobey, K. D., & Bennink, H. J. T. C. (2014) · Contraception · doi:10.1016/j.contraception.2014.11.002 · Cited by 16
Rohayem, J., Zitzmann, M., Laurentino, S., Kliesch, S., Nieschlag, E., Holterhus, P., & Kulle, A. E. (2020) · Clinical Endocrinology · doi:10.1111/cen.14324 · Cited by 12
Dehydroepiandrosterone replacement in addison’s disease
Kim, S. S., & Brody, K. H. (2001) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/s0301-2115(00)00500-5 · Cited by 12
Moran, F. M., Chen, J., Gee, N. A., Lohstroh, P. N., & Lasley, B. L. (2012) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0b013e3182698f80 · Cited by 11
Yao, Y., & Silver, R. (2022) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2022.877256 · Cited by 13
Dehydroepiandrosterone replacement therapy
Arlt, W. (2006) · Current Opinion in Endocrinology & Diabetes · doi:10.1097/01.med.0000224811.39318.73 · Cited by 11
Self-citationDehydroepiandrosterone and sport
Corrigan, A. B. (1999) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.1999.tb123601.x · Cited by 11
Dehydroepiandrosterone replacement therapy
Arlt, W., & Allolio, B. (2001) · Current Opinion in Endocrinology & Diabetes · doi:10.1097/00060793-200106000-00005 · Cited by 11
Self-citationAuchus, R. J. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-397175-3.00008-9 · Cited by 15
Systemic lupus erythematosus: a combined deficiency disease
Leung, L. H. (2004) · Medical Hypotheses · doi:10.1016/j.mehy.2004.01.017 · Cited by 9
Björk, Y., Knutsson, E. S., Ankarberg‐Lindgren, C., Broman, A.-K., Andersson, I., Björkman, L. I., Magnusson, J. M., Bergmark, K. H., Anderson, H., Andersson, P.-O., et al. (2016) · Bone Marrow Transplantation · doi:10.1038/bmt.2016.268 · Cited by 9
Dehydroepiandrosterone and ageing
Arlt, W. (2011) · doi:10.1093/med/9780199235292.003.0134 · Cited by 8
Self-citationŠulcová, J., Hampl, R., Hill, M., Stárka, L., & Nováček, A. (2005) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2005.038 · Cited by 8
Wu, S., Hao, P., Gou, C., Zhang, X., Wang, L., Basang, W., Zhu, Y., & Gao, Y. (2022) · Microorganisms · doi:10.3390/microorganisms10091745 · Cited by 8
Therapeutic glucocorticoid administration alters the diurnal pattern of dehydroepiandrosterone
Collomp, R., Labsy, Z., Zorgati, H., Prieur, F., Cottin, F., Do, M. C., Gagey, O., Lasne, F., & Collomp, K. (2013) · Endocrine · doi:10.1007/s12020-013-0122-9 · Cited by 10
What is past is prologue: estrogen/progestin replacement tomorrow
Oettel, M., Elger, W. A. G., Gräser, T., Holz, C., Lähteenmäki, P. L. A., & Patchev, V. K. (2001) · Gynecological Endocrinology · doi:10.1080/gye.15.s4.68.90 · Cited by 8
Self-citationTratamiento del deseo sexual hipoactivo de la mujer
Santamaría, F. C. (2007) · Revista Internacional de Andrología · doi:10.1016/s1698-031x(07)74031-1 · Cited by 12
Management of the androgen-deficient woman
Arlt, W. (2003) · Growth Hormone & IGF Research · doi:10.1016/s1096-6374(03)00060-1 · Cited by 7
Self-citationSandoval, D. A., Ping, L., Neill, R. A., Morrey, S., & Davis, S. N. (2004) · Diabetes · doi:10.2337/diabetes.53.3.679 · Cited by 7
Li, L., Yao, Y., Jiang, Z., Zhao, J., Cao, J., & Ma, H. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/2985956 · Cited by 7
Androgen Replacement Therapy in Androgen-Deficient Women with Hypopituitarism
Zang, H., & Davis, S. R. (2008) · Drugs · doi:10.2165/00003495-200868150-00001 · Cited by 7
Delayed diagnosis of Addison's disease: an approach to management
Mascarenhas, J. V., & Jude, E. B. (2014) · BMJ Case Reports · doi:10.1136/bcr-2014-204005 · Cited by 7
The role of androgens in hormone replacement therapy
Johnson, C., & Berman, J. R. (2005) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.6.11.1815 · Cited by 6
Androgen replacement therapy in women
Lebbe, M., Hughes, D., Reisch, N., & Arlt, W. (2012) · Expert Review of Endocrinology & Metabolism · doi:10.1586/eem.12.45 · Cited by 7
Self-citationCipriani, S., Maseroli, E., & Vignozzi, L. (2021) · Springer eBooks · doi:10.1007/978-3-030-77111-9_8 · Cited by 7
Hibino, H., Sakiyama, N., Makino, Y., Makihara-Ando, R., Horinouchi, H., Fujiwara, Y., Kanda, S., Goto, Y., Yoshida, T., Okuma, Y., et al. (2022) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-022-03275-5 · Cited by 5
Menopause hormonal therapy from the urologist’s perspective
Lightner, D. J. (2006) · Current Urology Reports · doi:10.1007/s11934-006-0030-0 · Cited by 5
Kocis, P. T. (2006) · American Journal of Health-System Pharmacy · doi:10.2146/ajhp060100 · Cited by 6
Zimmerman, Y., Wouters, W., & Bennink, H. J. T. C. (2013) · The European Journal of Contraception & Reproductive Health Care · doi:10.3109/13625187.2013.777831 · Cited by 4
Effect of dehydroepiandrosterone on meiotic spindle structure and oocyte quality in mice.
Moghadam, A. R. E., Saki, G., Hemadi, M., Mazaheri, Z., & Khodadadi, A. (2018) · PubMed Central · doi:10.22038/ijbms.2018.27111.6629 · Cited by 4
Iliev, D. I., Braun, R., Sánchez‐Guijo, A., Hartmann, M., Wudy, S. A., Heckmann, D., Bruchelt, G., Rösner, A., Grosser, G., Geyer, J., et al. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00240 · Cited by 6
Dehydroepiandrosterone and androstenedione
Allolio, B., Arlt, W., & Hahner, S. (2012) · Cambridge University Press eBooks · doi:10.1017/cbo9781139003353.021 · Cited by 5
Self-citationBiochemistry and Genetics of Human P450c17
Miller, W. L., & Auchus, R. J. (2000) · KARGER eBooks · doi:10.1159/000060844 · Cited by 4
Villaseca, P., Campino, C., Oestreicher, E. M., Mayerson, D., Serón‐Ferré, M., & Arteaga, E. (2004) · Human Reproduction · doi:10.1093/humrep/deh597 · Cited by 5
Condiciones metabólicas y hormonales en la menopausia
Hernández, L. M., & Hernández, J. M. M. (2006) · Revista de Endocrinología y Nutrición · Cited by 7
Dehydroepiandrosterone and Melatonin: Two Neurohormones
Caley, C. F. (1999) · Journal of Pharmacy Practice · doi:10.1177/089719009901200312 · Cited by 4
Andro and the Prosteroids: Bolting the Stable Door
Handelsman, D. J. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-2362 · Cited by 4
Anti-Aging: Mythen und Fakten zur Diagnose und Therapie
Zech, N. H. (2004) · Gyn�kologisch-geburtshilfliche Rundschau · doi:10.1159/000076864 · Cited by 4
Zimmerman, Y., Bennink, H. J. T. C., Wouters, W., Ebes, F., & Fauser, B. C. J. M. (2013) · The European Journal of Contraception & Reproductive Health Care · doi:10.3109/13625187.2013.822061 · Cited by 3
In rats, oral oleoyl-DHEA is rapidly hydrolysed and converted to DHEA-sulphate
Serrano, M., Grasa, M., Fernández–Löpez, J., & Alemany, M. (2007) · BMC Pharmacology · doi:10.1186/1471-2210-7-4 · Cited by 3
Adrenopause und Dehydroepiandrosteron: Pharmakotherapie versus Substitution
Römmler, A. (2003) · Gyn�kologisch-geburtshilfliche Rundschau · doi:10.1159/000069165 · Cited by 4
Hughes, I. A., & Chatterjee, K. (2015) · Elsevier eBooks · doi:10.1016/b978-0-323-18907-1.00105-0 · Cited by 3
Dehydroepiandrosterone Administration in Treating Medical and Neuropsychiatric Disorders
Ritsner, M. S. (2008) · Springer eBooks · doi:10.1007/978-1-4020-6854-6_17 · Cited by 5
Shibli-Rahhal, A. A., Haynes, W. G., Sinkey, C. A., & Dillon, J. S. (2012) · journal of Diabetes Research and Clinical Metabolism · doi:10.7243/2050-0866-1-13 · Cited by 2
Androgen therapy for low female libido
Mahmoud, M. S., Diamond, M. P., & Balon, R. (2006) · Sexuality, reproduction & menopause · doi:10.1016/j.sram.2006.08.006 · Cited by 2
Arlt, W. (2007) · Annales d Endocrinologie · doi:10.1016/j.ando.2007.06.016 · Cited by 3
Self-citationSoveizi, M., Mahdieh, N., Setoodeh, A., Sayarifard, F., Abbasi, F., Bose, H. S., Rabbani, B., & Rabbani, A. (2020) · International Journal of Endocrinology · doi:10.1155/2020/4329791 · Cited by 2
Dehydroepiandrosterone (DHEA) in relation to breast cancer
Chatterton, R. T. (2024) · Vitamins and hormones · doi:10.1016/bs.vh.2024.11.002 · Cited by 4
Approach to the patient: investigation of postmenopausal androgen excess
Madden-Doyle, L., Bowers, K., Sherlock, M., & O’Reilly, M. (2026) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgag221 · Cited by 1
Hughes, I. A., & Chatterjee, K. (2010) · Elsevier eBooks · doi:10.1016/b978-1-4160-5583-9.00104-0 · Cited by 1
Allolio, B., Nies, C., Moll, R., Klose, K., Kann, P. H., Pfestroff, A., Waldmann, J., Bartsch, D. K., Lehnert, H., Dralle, H., et al. (2012) · Springer eBooks · doi:10.1007/978-3-642-14285-7_4 · Cited by 1
Self-citationFaria, M. D. S., Nascimento, G. C., Faria, A. M., & Martins, M. R. A. (2022) · Springer eBooks · doi:10.1007/978-3-030-90684-9_7 · Cited by 2
Doping Status of DHEA Treatment for Female Athletes with Adrenal Insufficiency
Handelsman, D. J., Matsumoto, A. M., & GERRARD, D. F. (2016) · Clinical Journal of Sport Medicine · doi:10.1097/jsm.0000000000000300 · Cited by 3
Laureti, S., Santeusanio, F., & Falorni, A. (2001) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.11.12.1911 · Cited by 1
Weiß, A. G. (2024) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-10273 · Cited by 1
Psychosocial Aspects of the Menopause Psychosocial Aspects of the Menopause
Dooley, M., & Bell, B. B. (2007) · Springer eBooks · doi:10.1007/978-1-84628-808-1_27 · Cited by 2
Pregnancy Chances in Women over the Age of Forty
Al-Taee, H. A. J. (2013) · Asian Journal of Pharmacy Nursing and Medical Sciences · doi:10.24203/ajpnms.v1i4.544.g369
Androgenmangel bei Frauen: Wann klinisch relevant?
Jaursch-Hancke, C. (2014) · Journal für Kardiologie (Krause & Pachernegg GmbH)
Faut-il prescrire de la DHEA ?
Kuhn, J. M. (2005) · Annales d Endocrinologie · doi:10.1016/s0003-4266(05)81685-3
For information on reprint requests of more than 101 and commercial reprints contact
Barbour, L. A., Cobin, R. H., DeGroot, L. J., Glinoer, D., Mandel, S. J., & Edwards, H. A. (2008)
Aus der Medizinischen Klinik und Poliklinik I der
München, L.-M.-U., & Steinbeck, G. (2002)
Baes, C. V. W. (2016) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.17.2017.tde-27072016-152342 · Cited by 1
The Use of DHEA to Improve Oocyte Quality
Kroon, B. (2019) · Cambridge University Press eBooks · doi:10.1017/9781316756744.011
DHEA as a Putative Replacement Therapy in the Elderly
Genazzani, A. D., & Lanzoni, C. (2011) · CRC Press eBooks · doi:10.1201/b11019-4 · Cited by 3
Postprandial lipid profile and Androgen status in polycystic ovarian syndrome (PCOS)
Al-Saedi, S. Z., Al-Shamma, G. A. A., & Abdulla, H. (2013) · Karbala Journal of Medicine
Allolio, B., Barth, P. J., Dralle, H., Gimm, O., Hamberger, B., Klose, J., Lehnert, H., Machens, A., Moll, R., Mundschenk, J., et al. (2000) · Springer eBooks · doi:10.1007/978-3-662-09422-8_4
Self-citationUnderstanding immunesenescence
Phillips, A. C., Upton, J., Duggal, N. A., Deb, C., Randhawa, C., Oyebode, J. R., & Lord, J. M. (2018) · Policy Press eBooks · doi:10.2307/j.ctv3s8sjb.12
Bachelot, A. (2019) · Elsevier eBooks · doi:10.1016/b978-2-294-74372-6.00035-7
Faria, M. D. S., Nascimento, G. C., Faria, A. M., & Martins, M. R. A. (2013) · Springer eBooks · doi:10.1007/978-1-4614-8684-8_8
Understanding immunesenescence
Phillips, A. C., Upton, J., Duggal, N. A., Deb, C., Randhawa, C., Oyebode, J. R., & Lord, J. M. (2018) · Bristol University Press eBooks · doi:10.46692/9781447314813.008
Understanding immunesenescence
Phillips, A. C., Upton, J., Duggal, N. A., Deb, C., Randhawa, C., Oyebode, J. R., & Lord, J. M. (2018) · Policy Press eBooks · doi:10.51952/9781447314813.ch007
Autopoiesis, intracrinology, and the self: toward a new model of mental health
Gordon, S. (2025) · Academia Mental Health and Well-Being · doi:10.20935/mhealthwellb7727
Metadata
- Authors
- Arlt, W., Justl, H.-G., Callies, F., Reincke, M., Hübler, D., Oettel, M., Ernst, M., Schulte, H. M., & Allolio, B.
- Affiliations
- Universitätsklinikum Würzburg (DE)
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 1998-06
- Volume
- 83
- Issue
- 6
- Pages
- 1928-1934
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2004648105
- Cited by
- 199
- References
- 42
- Citations by year
- 2026: 1 · 2025: 2 · 2024: 2 · 2022: 6 · 2021: 1 · 2020: 4 · 2019: 7 · 2018: 9 · 2017: 4 · 2016: 6 · 2015: 4 · 2014: 8 · 2013: 10 · 2012: 8
- FWCI
- 6.49
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- FreiDok plus (Universitätsbibliothek Freiburg) (submittedVersion)
- University of Birmingham Research Portal (University of Birmingham) (submittedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal Regulation and Hypertension
- Keywords
- dehydroepiandrosterone, DHEA sulfate, adrenal insufficiency, pharmacokinetics, dexamethasone suppression, androstenedione, dihydrotestosterone, estrone, testosterone, dose optimization, women, healthy volunteers, follicular phase, cortisol suppression, oral administration
- MeSH terms
- Administration, Oral, Adrenal Insufficiency, Adult, Androgens, Androstenedione, Dehydroepiandrosterone, Dexamethasone, Estrogens, Estrone, Female, Follicular Phase, Humans, Hydrocortisone, Dihydrotestosterone, Testosterone, Cross-Over Studies, Dehydroepiandrosterone Sulfate
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.